Insilico Medicine Posts First Profit, $106.3M Revenue in First Half of 2026
Unite.AI
Read full postInsilico Medicine, a clinical-stage AI drug discovery company, reported its first profit with $106.3M revenue in H1 2026, mainly from dealmaking rather than product sales. Key deals include collaborations with SK Biopharmaceuticals and Takeda Pharmaceutical, supporting its drug pipeline advancement.



